Author:
Yang Shao-Mei,Huang Zhi-Ning,Zhou Zhong-Shi,Hou Jin,Zheng Man-Yi,Wang Li-Juan,Jiang Yu,Zhou Xin-Yi,Chen Qiu-Yue,Li Shan-Hua,Li Fu-Nan
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference13 articles.
1. Abou-Alfa, G.K., L. Schwartz, S. Ricci, D. Amadori, A. Santoro, A. Figer, J. De Greve, J.Y. Douillard, C. Lathia, B. Schwartz, I. Taylor, M. Moscovici, and L.B. Saltz. 2006. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. Journal of Clinical Oncology 24: 4293–4300.
2. Bedos-Belval, F., A. Rouch, C. Vanucci-Bacqué, and M. Baltas. 2012. Diaryl ether derivatives as anticancer agents–a review. MedChemComm 3: 1356–1372.
3. Gupta-Abramson, V., A.B. Troxel, A. Nellore, K. Puttaswamy, M. Redlinger, K. Ransone, S.J. Mandel, K.T. Flaherty, L.A. Loevner, P.J. O’dwyer, and M.S. Brose. 2008. Phase II trial of sorafenib in advanced thyroid cancer. Journal of Clinical Oncology 26: 4714–4719.
4. Huang, T.T., Y.C. Huang, X.Y. Qing, Y. Xia, X. Luo, T.H. Ye, and L.T. Yu. 2012. Synthesis and biological evaluation of novel N-methyl-picolinamide-4-thiol derivatives as potential antitumor agents. Molecules 17: 6317–6330.
5. Jemal, A., F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman. 2011. Global cancer statistics. CA: A Cancer Journal for Clinicians 61: 69–90.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献